McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, ...

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on McKesson (MCK – Research Report), with a ...

Geneos Wealth Management Inc. increased its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 5.6% in the 4th ...

McKesson's strategic growth in oncology, biopharma and tech drives momentum in 2025. Will MCK overcome its sustaining challenges with robust finances and innovation?

Shares of McKesson Co. (NYSE:MCK – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are covering the firm, Marketbeat reports. Two investment ...

Larry Robbins is an American hedge fund manager, philanthropist, and the founder, CEO, and portfolio manager of Glenview ...

A grant to the University of Illinois Chicago Rockford expands their pharmacy program to focus on rural communities.

McKesson Corporation (MCK ... of growth from GLP-1 medications and a robust oncology network business. Vertex Pharmaceuticals (VRTX) comes in second with a score of 4.04 and a Buy rating given ...

The S&P 500’s health care sector (NYSEARCA:XLV), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 10.2% in Q4 and is the fourth lowest scored sector by the SA Quant rating system.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

In this article, we are going to take a look at where McKesson Corporation (NYSE ... namely healthcare benefit managers and pharmaceutical chains, into Wall Street's spotlight.